TA invests in Ideal Cures

#TA Associates, a leading global growth private equity firm, has completed an investment in India’s #Ideal Cures Private Limited, which has expansion plans in the healthcare sector.

Financial terms of the transaction were not disclosed in the announcement made on 14 March 2017.

Founded in 1999 in India, Ideal Cures supplies ready to-use coating products and excipients for tablets and capsules to the pharmaceutical and allied industries.

Ideal Cures has three manufacturing plants located in Vasai, Jammu and Khambat. It also has two state-of-the-art R&D facilities in Mumbai and Vasai while another plant is under construction in Sikkim.

“We believe that Ideal Cures has a robust business strategy, and over the last few years has emerged as a provider of high quality products and services in the tablet coating space, with a vast and diversified customer base globally,” said Dhiraj Poddar, Country Head of India, TA Associates Advisory Private Limited, who will join the Ideal Cures Board of Directors.

“Ideal Cures has worked diligently to innovate solutions that meet the needs of the pharmaceutical and allied industries, building exceptional manufacturing, research and development, and technical services capabilities to rapidly expand their operations. We are thrilled to have the opportunity to partner with Ideal Cures and we look forward to helping their experienced team to drive growth,” he said.

TA Associates believes that the trend is to outsource the production of ready-to-use, fully-formulated coatings, which is being driven most notably by companies seeking innovative solutions that reduce processing time and a company’s carbon foot print such as Ideal Cures provides.

“To be a preferred global supplier of coatings and excipients, we have made it our mission over the course of our more than 15-year history to provide our customers with pioneering research and development, excellent technical support and good manufacturing practices,” said Suresh Pareek, Founder and Managing Director of Ideal Cures.

“We are confident that TA Associates’ experience of investing in the healthcare sector will provide the financial and operational expertise to help us expand upon our solutions. We are pleased to welcome TA’s investment and look forward to benefitting from this partnership.”

“Ideal Cures’ business, which is focused on innovation, best-in-class products, state-of-the art facilities and a well-trained and committed professional workforce, continues to evolve,” said Kamlesh Oza, President – Global Business Development at Ideal Cures.

“With the advent of TA Associates coming on board, Ideal Cures aims to leverage TA’s networking and other corporate development capabilities to accelerate growth in not only some of the fastest growing regions, like South Asia, but also in well established markets around the world,” said Oza.

“We believe that the film coating industry is a unique, yet evolving sector that has strong potential for growth globally,” said Naveen A. Wadhera, a Managing Director at TA Associates.

“We expect that there are significant opportunities for expansion and are eager to help Ideal Cures further develop and enhance its brand and internal capabilities. We are delighted that Ideal Cures has chosen to partner with TA and look forward to helping them execute on their strategic vision,” Wadhera said.

#K Law served as legal counsel to Ideal Cures and #DSK Legal served as legal counsel to TA Associates.

TA Associates Advisory Private Limited provided advisory services on the investment. It has invested in more than 480 companies around the world and has raised US$24 billion in capital. With offices in Boston, Menlo Park, London, Mumbai and Hong Kong. fii-news.com